Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Endres, Christopher J.
221  Ergebnisse:
Personensuche X
?
1

nhanesA: achieving transparency and reproducibility in NHAN..:

Ale, Laha ; Gentleman, Robert ; Sonmez, Teresa Filshtein..
Database.  2024 (2024)  - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Creation of Novel Sensitive Probe Substrate and Moderate In..:

Templeton, Ian E. ; Rowland‐Yeo, Karen ; Jones, Hannah M....
Clinical Pharmacology & Therapeutics.  115 (2023)  2 - p. 299-308 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Effect of Tucatinib on Cardiac Repolarization in Healthy Vo..:

Topletz-Erickson, Ariel R. ; Mayor, JoAl G. ; Liu, Hsu-Tai..
Drugs in R&D.  23 (2023)  4 - p. 411-419 , 2023
Link: https://doi.org/10.1007/..
 
?
4

The Iron Deficiency-Regulated Small Protein Effector FEP3/I..:

Lichtblau, Daniela M. ; Schwarz, Birte ; Baby, Dibin...
Frontiers in Plant Science.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
5

Elimination of tucatinib, a small molecule kinase inhibitor..:

Sun, Hao ; Cardinal, Kristen A. ; Wienkers, Larry...
Cancer Chemotherapy and Pharmacology.  89 (2022)  6 - p. 737-750 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Evaluation of Safety and Clinically Relevant Drug–Drug Inte..:

Topletz-Erickson, Ariel ; Lee, Anthony ; Rustia, Evelyn L....
Clinical Pharmacokinetics.  61 (2022)  10 - p. 1417-1426 , 2022
Link: https://doi.org/10.1007/..
 
?
7

The Pharmacokinetics and Safety of Tucatinib in Volunteers ..:

Topletz-Erickson, Ariel R. ; Lee, Anthony J. ; Mayor, JoAl G....
Clinical Pharmacokinetics.  61 (2022)  12 - p. 1761-1770 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Risk‐Based Pharmacokinetic and Drug–Drug Interaction Charac..:

Li, Chunze ; Menon, Rajeev ; Walles, Markus...
Clinical Pharmacology & Therapeutics.  112 (2021)  4 - p. 754-769 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Tucatinib Inhibits Renal Transporters OCT2 and MATE Without..:

Topletz‐Erickson, Ariel R. ; Lee, Anthony J. ; Mayor, JoAl G....
The Journal of Clinical Pharmacology.  61 (2020)  4 - p. 461-471 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Population Pharmacokinetic Modeling and Exposure–Response A..:

Suri, Ajit ; Mould, Diane R. ; Song, Gregory...
Clinical Pharmacology & Therapeutics.  106 (2019)  6 - p. 1268-1279 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Neuroimaging of translocator protein in patients with syste..:

Wang, Yuchuan ; Coughlin, Jennifer M ; Ma, Shuangchao...
Lupus.  26 (2016)  2 - p. 170-178 , 2016
Link: https://doi.org/10.1177/..
 
?
12

The role of the equilibrative nucleoside transporter 1 on t..:

Endres, Christopher J. ; Moss, Aaron M. ; Ishida, Kazuya..
Biopharmaceutics & Drug Disposition.  37 (2016)  6 - p. 336-344 , 2016
Link: https://doi.org/10.1002/..
 
?
13

Regional brain distribution of translocator protein using [..:

Coughlin, Jennifer M. ; Wang, Yuchuan ; Ma, Shuangchao...
Journal of NeuroVirology.  20 (2014)  3 - p. 219-232 , 2014
Link: https://doi.org/10.1007/..
 
?
14

A semi‐mechanistic model to characterize the pharmacokineti..:

Salinger, David H. ; Endres, Christopher J. ; Martin, David A..
Clinical Pharmacology in Drug Development.  3 (2014)  4 - p. 276-283 , 2014
Link: https://doi.org/10.1002/..
 
?
15

Population pharmacokinetics of brodalumab in healthy adults..:

Endres, Christopher J. ; Salinger, David H. ; Köck, Kathleen...
The Journal of Clinical Pharmacology.  54 (2014)  11 - p. 1230-1238 , 2014
Link: https://doi.org/10.1002/..
 
1-15
Mehr Literatur finden
Friedrich Hölderlin